- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
HBA Releases New Data on Workplace Equality
Workplace equality accelerating for healthcare industry’s Gender Parity Collaborative.
The Gender Parity Collaborative, an award-winning consortium led by the Healthcare Businesswomen’s Association (HBA), has released a report presenting new data marking the significant headway their healthcare and life- sciences partner companies are making towards gender and workplace equality, outperforming peers and various industries altogether.
Insights and Impact 2021 details progress and achievements made during a two-year period, from the consortium’s founding in 2018 through 2020, including substantial increases in women’s representation specifically in leadership roles at the VP level and above.
Read more about the report here.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
